DRUG
Bright Minds Biosciences Inc. Health Care Pharmaceutical Preparations Russell 3000
$54.98Close
$48.25 – $95.9952-week range
Dec 22, 2026Next report
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 13 · weaker than 87% of stocks over 12 months
- Far from its high 43% below its 52-week high
- Distribution down-day volume 1.5× up-day volume over 50 sessions
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
6.4%
$3.50 a day · 2×ATR $47.99
RS
13 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
0.65
50 sessions
Implied move
—
no option chain · report Dec 22, 2026
Trend template · 0 of 8
Screen verdict
Not scorable — no classified balance sheet.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Dec 31, 2024 | Annual ↗ | — | 0d |
| Dec 29, 2023 | Annual ↗ | — | 0d |
| Dec 29, 2022 | Annual ↗ | — | 0d |
| Dec 29, 2021 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 2, 2026 | Foreign issuer report ↗ |
| Oct 1, 2026 | Foreign issuer report ↗ |
| Aug 17, 2026 | Foreign issuer report ↗ |
| Jun 3, 2026 | Foreign issuer report ↗ |
| Jun 2, 2026 | Foreign issuer report ↗ |
| May 28, 2026 | Foreign issuer report ↗ |
| May 20, 2026 | Foreign issuer report ↗ |
| Feb 13, 2026 | Foreign issuer report ↗ |
| Jan 9, 2026 | Foreign issuer report ↗ |
| Jan 9, 2026 | Foreign issuer report ↗ |
| Jan 8, 2026 | Foreign issuer report ↗ |
| Jan 7, 2026 | Foreign issuer report ↗ |